文献速递医学教育与科研方法临床试验与 GCP

WILL试验管理团队开展有效患者与公众参与及介入(PPIE)的经验

Experiences of conducting effective Patient and Public Involvement and Engagement (PPIE) by the WILL Trial (When to Induce Labour to Limit risk in pregnancy hypertension) management team.
PubMed 文献 · Trials · 2026-01-21

WILL试验管理团队通过国家资源招募7名多元PPIE成员,经4次会议和15次迭代共同设计妊娠期高血压风险信息图,历时9个月获伦理批准;伦理委员会要求将死产风险表述由「1/1000」改为「小幅增加风险」。

要点

  • 7名PPIE成员来自NIHR和APEC,无活跃站点参与者。
  • 信息图经4次会议、15次迭代,从启动到伦理批准历时9个月。
  • 伦理委员会要求将死产风险「1/1000」改为「小幅增加风险」。

核心结论

  • 研究者建立PPIE小组需要更多实际支持,审查共同制作资源的伦理委员会亦然。
  • 本案例提供无资助联合负责人的PPIE小组建立步骤,强调成员多样性、文化视角和包容性患者材料。
  • 研究结果通过操作指导、经验教训和总结清单补充现有高层框架。

研究设计与样本

  • 基于英国国家资源(NIHR和健康研究管理局)招募PPIE成员,联系活跃站点并投放广告。
  • PPIE成员共7名,6名来自NIHR People in Research,1名来自APEC,无成员来自活跃站点。
  • 通过虚拟会议共同设计信息图,共召开4次会议,开发15个迭代版本。

主要发现

  • 从初始建立到伦理委员会批准信息图历时9个月,试验经理和高级研究助产士投入大量时间。
  • 信息图纳入PPIE成员对包容所有种族、文化、能力和性别设计的要求。
  • 与PPIE成员讨论增进了对试验干预在某些文化中可接受性的理解。
  • 伦理委员会要求将PPIE批准的关于死产风险的措辞从「1/1000」修改为「小幅增加风险」后方批准使用。

局限性

  • 无成员来自活跃站点。
  • 研究者建立PPIE小组需要更多实际支持。
  • 审查共同制作资源的伦理委员会需要更多实际支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patient and Public Involvement and Engagement (PPIE) is an essential element of any clinical trial, to ensure that the research design and resources are acceptable and the trial produces findings that are relevant to research participants and service-users. The WILL (When to Induce Labour to Limit risk in pregnancy hypertension) Trial Management Team involved a group of patient and public members to develop an infographic, for service-users and -providers, to communicate the risks of chronic and gestational hypertension at term gestational age. METHODS: Based on national resources in the UK for PPIE, including those from the National Institute for Health and Care Research (NIHR) and Health Research Authority, active trial sites (all in the UK) were approached to invite women with pregnancy hypertension to the PPIE group, and advertisements were placed on the Action on Pre-Eclampsia Charity (APEC) and NIHR People in Research websites. PPIE resources were established by the Trial Management Team and virtual meetings with the PPIE members held to co-design and develop the infographic from existing trial materials, using Microsoft Publisher. RESULTS: Seven diverse PPIE members were involved, six from NIHR People in Research and one from APEC. No members were engaged from active sites. From initial set-up to REC approval of the infographic took 9 months, and a considerable time commitment from the Trial Manager and Senior Research Midwives, to navigate practicalities (e.g. team consensus-building). Four meetings were held and 15 iterations of the infographic were developed with the group. The infographic incorporated requests from PPIE members for a design that was inclusive of all races, cultures, abilities and genders. Discussions with PPIE group members improved our understanding of the acceptability of the trial intervention to some cultures. The Research Ethics Committee (REC) requested revisions to PPIE-approved wording about the risk of stillbirth, from '1 in 1000' to 'small increased risk' prior to issuing approval for use. CONCLUSIONS: More practical support would be useful for researchers seeking to establish PPIE groups, and RECs reviewing resources that are co-produced. Our case study provides a practical, step-by-step account of establishing a PPIE group without a funded co-lead, highlighting strengths such as the diversity of members, the incorporation of cultural perspectives, and the development of inclusive patient-facing materials. These findings add to PPIE practice by offering operational guidance, lessons learned and a summary checklist as an additional resource that can complement existing high-level frameworks. TRIAL REGISTRATION: ISRCTN77258279, registered on 05 December 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kirkham K, Tohill S, Wade J, et al. Experiences of conducting effective Patient and Public Involvement and Engagement (PPIE) by the WILL Trial (When to Induce Labour to Limit risk in pregnancy hypertension) management team. Trials. 2026. PMID: 41566476. doi:10.1186/s13063-025-09218-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。